In addition, restoring miR-16 in NSCLC cells not only inhibits key oncogenic pathways such as ERK/MAPK but also renders the cancer cells more susceptible to cisplatin and EGFR inhibitors in xenograft models [8]. Here, EGFR is linked to non-small cell lung carcinoma.